Literature DB >> 16928864

Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission.

Paul J Gasser1, Christopher A Lowry, Miles Orchinik.   

Abstract

Glucocorticoid hormones act within the brain to alter physiological and behavioral responses to stress-related stimuli. Previous studies indicated that acute stressors can increase serotonin [5-hydroxytryptamine (5-HT)] concentrations in the dorsomedial hypothalamus (DMH), a midline hypothalamic structure involved in the integration of physiological and behavioral responses to stress. The current study tests the hypothesis that rapid, stress-induced accumulation of 5-HT is attributable to the inhibition of 5-HT transport via organic cation transporters (OCTs). OCTs are a family of high-capacity, bidirectional, multispecific transporters of organic cations (including 5-HT, dopamine, and norepinephrine) only recently described in brain. In peripheral tissues, organic cation transport via some OCTs is inhibited by corticosterone. We examined the expression and function of OCTs in the periventricular medial hypothalamus of male Sprague Dawley rats using reverse-transcriptase (RT)-PCR, immunohistochemistry, and in vitro transport assays. RT-PCR revealed expression of OCT3 mRNA, but not OCT1 or OCT2 mRNA, in the medial hypothalamus. OCT3-like immunoreactivity was observed in ependymal and glial-like cells in the DMH. Acutely prepared minces of rat medial hypothalamic tissue accumulated the OCT substrates [3H]-histamine and [3H]-N-methyl-4-phenylpyridinium ([3H]-MPP+). Consistent with the pharmacological profile of OCT3, corticosterone, 5-HT, estradiol, and the OCT inhibitor decynium22 dose-dependently inhibited histamine accumulation. Corticosterone and decynium22 also inhibited efflux of [3H]-MPP+ from hypothalamic minces. These data support the hypothesis that corticosterone-induced inhibition of OCT3 mediates stress-induced accumulation of 5-HT in the DMH and suggest that corticosterone may acutely modulate physiological and behavioral responses to stressors by altering serotonergic neurotransmission in this brain region.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16928864      PMCID: PMC6674371          DOI: 10.1523/JNEUROSCI.0570-06.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  67 in total

1.  Projections of the median raphe nucleus in the rat.

Authors:  R P Vertes; W J Fortin; A M Crane
Journal:  J Comp Neurol       Date:  1999-05-17       Impact factor: 3.215

2.  Rapid changes in monoamine levels following administration of corticotropin-releasing factor or corticosterone are localized in the dorsomedial hypothalamus.

Authors:  C A Lowry; K A Burke; K J Renner; F L Moore; M Orchinik
Journal:  Horm Behav       Date:  2001-05       Impact factor: 3.587

3.  Serotonergic responses to corticosterone and testosterone in the limbic system.

Authors:  C H Summers; E T Larson; P J Ronan; P M Hofmann; A J Emerson; K J Renner
Journal:  Gen Comp Endocrinol       Date:  2000-01       Impact factor: 2.822

4.  Vesicular monoamine transporter 1 is responsible for storage of 5-hydroxytryptamine in rat pinealocytes.

Authors:  M Hayashi; M Haga; S Yatsushiro; A Yamamoto; Y Moriyama
Journal:  J Neurochem       Date:  1999-12       Impact factor: 5.372

5.  Pharmacological characterization and visualization of the glial serotonin transporter.

Authors:  M Inazu; H Takeda; H Ikoshi; M Sugisawa; Y Uchida; T Matsumiya
Journal:  Neurochem Int       Date:  2001-07       Impact factor: 3.921

6.  Selective substrates for non-neuronal monoamine transporters.

Authors:  D Gründemann; G Liebich; N Kiefer; S Köster; E Schömig
Journal:  Mol Pharmacol       Date:  1999-07       Impact factor: 4.436

7.  Molecular mechanisms of organic cation transport in OCT2-expressing Xenopus oocytes.

Authors:  M Okuda; Y Urakami; H Saito; K Inui
Journal:  Biochim Biophys Acta       Date:  1999-03-04

8.  The extraneuronal monoamine transporter Slc22a3/Orct3 co-localizes with the Maoa metabolizing enzyme in mouse placenta.

Authors:  S Verhaagh; D P Barlow; R Zwart
Journal:  Mech Dev       Date:  2001-01       Impact factor: 1.882

9.  Pharmacological characterization of dopamine transport in cultured rat astrocytes.

Authors:  M Inazu; N Kubota; H Takeda; J Zhang; Y Kiuchi; K Oguchi; T Matsumiya
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

10.  Regulation of 5-hydroxytryptamine metabolism in mouse brain by adrenal glucocorticoids.

Authors:  L Neckers; P Y Sze
Journal:  Brain Res       Date:  1975-07-25       Impact factor: 3.252

View more
  48 in total

1.  Organic cation transporter inhibition increases medial hypothalamic serotonin under basal conditions and during mild restraint.

Authors:  Na Feng; Christopher A Lowry; Jodi L Lukkes; Miles Orchinik; Gina L Forster; Kenneth J Renner
Journal:  Brain Res       Date:  2010-02-19       Impact factor: 3.252

2.  Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression.

Authors:  Rebecca E Horton; Deana M Apple; W Anthony Owens; Nicole L Baganz; Sonia Cano; Nathan C Mitchell; Melissa Vitela; Georgianna G Gould; Wouter Koek; Lynette C Daws
Journal:  J Neurosci       Date:  2013-06-19       Impact factor: 6.167

3.  Constitutive plasma membrane monoamine transporter (PMAT, Slc29a4) deficiency subtly affects anxiety-like and coping behaviours.

Authors:  T Lee Gilman; Christina M George; Melissa Vitela; Myrna Herrera-Rosales; Mohamed S Basiouny; Wouter Koek; Lynette C Daws
Journal:  Eur J Neurosci       Date:  2018-05-24       Impact factor: 3.386

4.  Regional characteristics of histamine uptake into neonatal rat astrocytes.

Authors:  Katja Perdan-Pirkmajer; Sergej Pirkmajer; Andreja Raztresen; Mojca Krzan
Journal:  Neurochem Res       Date:  2013-04-03       Impact factor: 3.996

5.  Interaction of stress and stimulants in female rats: Role of chronic stress on later reactivity to methamphetamine.

Authors:  Eden M Anderson; Lisa M McFadden; Leslie Matuszewich
Journal:  Behav Brain Res       Date:  2019-08-23       Impact factor: 3.332

Review 6.  Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.

Authors:  Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Ther       Date:  2011-04-05       Impact factor: 12.310

7.  Corticosterone Potentiation of Cocaine-Induced Reinstatement of Conditioned Place Preference in Mice is Mediated by Blockade of the Organic Cation Transporter 3.

Authors:  Jayme R McReynolds; Analisa Taylor; Oliver Vranjkovic; Terra Ambrosius; Olivia Derricks; Brittany Nino; Beliz Kurtoglu; Robert A Wheeler; David A Baker; Paul J Gasser; John R Mantsch
Journal:  Neuropsychopharmacology       Date:  2016-09-08       Impact factor: 7.853

8.  Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling.

Authors:  T Couroussé; A Bacq; C Belzung; B Guiard; L Balasse; F Louis; A-M Le Guisquet; A M Gardier; A H Schinkel; B Giros; S Gautron
Journal:  Mol Psychiatry       Date:  2014-08-05       Impact factor: 15.992

9.  Influence of chronic amphetamine treatment and acute withdrawal on serotonin synthesis and clearance mechanisms in the rat ventral hippocampus.

Authors:  Jeffrey L Barr; Jamie L Scholl; Rajeshwari R Solanki; Michael J Watt; Christopher A Lowry; Kenneth J Renner; Gina L Forster
Journal:  Eur J Neurosci       Date:  2012-11-14       Impact factor: 3.386

10.  5-HT(1B) autoreceptor regulation of serotonin transporter activity in synaptosomes.

Authors:  Catherine E Hagan; Ross A McDevitt; Yusha Liu; Amy R Furay; John F Neumaier
Journal:  Synapse       Date:  2012-09-29       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.